Consult with a healthcare practitioner to see if a Sculptra®
treatment is right for you.
The regenerative biostimulator that renews skin from within 1-12,27
Over time, we may feel we don’t look like we used to — that our face has started to sag and our skin looks dull and tired. Sculptra® is a regenerative treatment — the first proven regenerative biostimulator — that helps address multiple skin concerns1,5,15-18 while delivering progressive, natural-looking, and long-lasting results for more than 2 years.2-4,6-11 Whether you are looking for:
- Improved skin quality for a radiant,
youthful glow 6,13,27
- Renewed volume 2,6,12,27
- A lifted appearance 6,14
Patients who reported improvement in skin firmness 2 years after treatment6
Patients who reported an improvement in skin radiance (glow) 2 years after treatment6
Of patients maintained enhanced jawline definition 2 years after treatment.6
Sculptra®
The first proven regenerative biostimulator
Sculptra® is the first proven regenerative biostimulator that helps restore the skin’s structure.1,5,6,15-19
It stimulates collagen and elastin, strengthening your skin’s foundation, increasing its healthy thickness and restoring firmness over time.2-4,7,11,12-13,20-23
‘‘ Having rejuvenated skin just made me feel happier [and] younger so I could get up and go. It looks natural and dewy. ’’
CHLOE 39 YEARS OLD
Rejuvenated, firm and radiant skin lasting more than 2 years 2,6,24
Stay true to you! Sculptra® works progressively by increasing your own collagen and elastin,1-4,7,11,12-13.20-23 with visible results already 1 month after treatment and that last for more than 2 years.1-2,4,6
Frequently asked questions
How long does it take to see results with Sculptra®?
You will start to notice visible results already after one month.2,4,6 Sculptra® works progressively, so there will be a gradual improvement in skin firmness, radiance and volume over time.2,6,11,13,24-26
How long do the results from Sculptra® last?
One of the best things about Sculptra® is how long it lasts. The treatment provides rejuvenated skin for more than 2 years.2,4,6
Is there any downtime after a Sculptra® treatment?
Good news—there’s minimal downtime with Sculptra®! In general, you might have some swelling or redness for a few days, but most people get back to their normal routine pretty quickly.1 Remember to always consult a healthcare practitioner for individualized treatment recommendations and to discuss the safety information and potential risks associated with the use of Sculptra®.
1. Sculptra® Instructions for Use EU 2020. 2. Brandt FS, et al. Aesthet Surg J. 2011;31(5):521–8. 3. Fabi S, et al. Dermatol Surg. 2024;50:1137–42. 4. Narins RS, et al. J Am Acad Dermatol. 2010;62(3):448–62. 5. Widgerow A, et al. A randomized, comparative study describing the gene signatures of poly-L-lactic Acid (PLLA-SCA™) and calcium hydroxylapatite (CaHA) in the treatment of nasolabial folds. Poster, IMCAS World Congress, 1–3 Feb 2024, Paris. 6. Fabi S, et al. Poster: Effectiveness and safety of correction of cheek wrinkles using a biostimulatory poly-L-lactic acid injectable implant—clinical study data up to 24 months. IMCAS World Congress, 26–28 Jan 2023, Paris. 7. Huth S, et al. J Drugs Dermatol. 2024;23(4):285–8. 8. U.S. FDA. Summary of Safety and Effectiveness Data: Sculptra (P030050/S039). (Accessed Aug 2025). 9. Galderma. Data on file (MA-54151). 10. Galderma. Data on file (MA-46589). 11. Goldberg D, et al. Dermatol Surg. 2013;39(6):915–22. 12. Valantin MA, et al. AIDS. 2003;17(17):2471–7. 13. Bohnert K et al. Dermatol Surg. 2019; 45(5):718–24. 14. Galderma. Data on file (MA-50526). 15. Galderma Receives FDA Approval for New SCULPTRA® Label, Offering More Options to Aesthetic Partners. Galderma. 2021. Available from: https://www.galderma.com/news/galderma-receives-fda-approvalnew-sculptra-label-offering-more-options-aesthetic-partners [Last accessed June 2024]. 16. U.S. Patent US 7,731,758 B22(010):2010 17. Sanofi S.r.l. DEKRA EN ISO 13485:2016 Certificate. Certificate effective since: February 2023. 18. Zhang Y, et al. Regen Biomater 2021;8(5):rbab042. 19. Data on file (MA-48331). 20. Galderma. Data on file (MA-60875). 21. Arruda S et al. J Drugs Dermatol. 2024; 23(9):729–34. 22. Galderma. Data on file. GLI.04.US.SL.020 Clinical Study Report. Dallas, TX: Galderma Laboratories, L.P.; 2024. 23. Hexsel D et al. Dermatol Surg. 2020; 46(8):1122–4. 24. Fabi S, et al. Skin movement and volume changes with poly-L lactic acid (PLLA-SCA) injectable implant. Poster presented at the International Master Course on Aging Science (IMCAS) World Congress. 26–28 January 2023. Paris, France. 25. Mest DR, Humble G. Dermatol. Surg. 2006;32(11):1336–45. 26. Filho CDSM, et al. Surg Cosmet Dermatol. 2013;5(4):345–50. 27. Haddad A, et, al. Utilizing the AART Methodology to maximize aesthetic treatment outcomes using poly-L-lactic acid (PILLA-SCA) for the improvement in Appearance of Cellulite - a Pilot Study. Poster presented at IMCAS. 01-03 February 2024. Paris, France.
DOCUMENT ID: GL-SCU-2400132
This material refers to the product certified under Regulation (EU) 2017/745 (MDR). Legacy versions of the product remain available. For full product information and the Instructions for Use (IFU), visit: www.galderma.com/library
Always consult a healthcare professional for individualized treatment recommendations and to discuss important
safety information and risks associated with the use of the products.